Here's Why Momenta Pharmaceuticals Dropped 13.5% Today
Without any meaningful revenue, Momenta Pharmaceuticals' (NASDAQ: MNTA) second-quarter report was rather uneventful, so it's a little surprising to see shares down 13.5% today without any significant news.But perhaps the lack of news is what's making short-term investors head for the exits.